Applied BioCode (6598) — Cash Flow Reinvestment Rate

Latest as of September 2022: 2.85x

Applied BioCode (6598) has a Cash Flow Reinvestment Rate of 2.85x as of September 2022, reinvesting NT$18.11 Million (capex NT$12.00 Million plus investments NT$-6.11 Million) from operating cash flow of NT$6.35 Million. Explore how much does Applied BioCode reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2.85x

(Capex + Investments) / Operating CF

Total Reinvested

NT$18.11 Million

Capex + Investments

Operating Cash Flow

NT$6.35 Million

TWD

Capital Expenditures

NT$12.00 Million

TWD

Applied BioCode Cash Flow Reinvestment Rate (2022–2022)

Historical reinvestment intensity for Applied BioCode across 1 annual periods. Also explore 6598 asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Applied BioCode (2022–2022)

Year-by-year capital reinvestment analysis for Applied BioCode. For live market cap and broader valuation context, see how much is Applied BioCode worth.

Year	Reinvestment Rate	Total Reinvested (TWD)	Operating CF	Capex	YoY Change
2022	0.30x	NT$44.28 Million	NT$145.87 Million	NT$22.14 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow